Defining an optimal cut-off point for reticulocyte hemoglobin as a marker for iron deficiency anemia: An ROC analysis
PLOS ONE · 13.07.2023 · 18 (7) · e0288505
DOI: 10.1371/journal.pone.0288505 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 13.07.2023. Verfasst von Marah Alzu'bi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, University of Jordan, Amman, Jordan. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Reticulocyte hemoglobin (CHr) is a measure of the amount of hemoglobin in reticulocytes and a marker of cell hemoglobinization. In this study, we aimed to find the optimal cut-off point for reticulocyte hemoglobin to diagnose iron deficiency anemia using multiple methods. A total of 309 patients were included. The median age at diagnosis was 54 years. Most were females (71.2%). 68% had iron deficiency anemia. Patients with IDA had significantly lower levels of CHr compared to those who had non-IDA (p < 0.0001). The optimal cut-off value of CHr for detecting IDA, determined using various methods, was 30.15 pg. This cut-off point had a sensitivity of 87.8% and a specificity of 77.7%. CHr showed a significant positive correlation with hemoglobin, mean corpuscular volume, serum iron, serum ferritin, and transferrin saturation and a significant negative correlation with total iron-binding capacity. CHr levels correlate with most established laboratory tests for IDA. It reliably detects IDA. Our results indicate the importance of CHr in diagnosing IDA, and that CHr should be used more widely in suspected cases of IDA since it is a cheap, fast, and reliable test.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical School, University of Jordan, Amman, Jordan.
- Al-Basheer Hospital, Ministry of Health, Amman, Jordan.
- Jordan University Hospital, Amman, Jordan.
- Cell Therapy Center, University of Jordan, Amman, Jordan.
ORCID-Profile: Marah Alzu'bi, Jawad Alrawabdeh, Yazan Hamadneh, Mai AlAdwan, Abdalla Awidi
Zitieren
APA
Alzu'bi, M., Bawa'neh, H., Alshorman, A., Alrawabdeh, J., Odeh, N., Hamadneh, Y., AlAdwan, M., Odeh, M., & Awidi, A. (2023). Defining an optimal cut-off point for reticulocyte hemoglobin as a marker for iron deficiency anemia: An ROC analysis. PLOS ONE, 18(7), e0288505. https://doi.org/10.1371/journal.pone.0288505
Vancouver
Alzu'bi M, Bawa'neh H, Alshorman A, Alrawabdeh J, Odeh N, Hamadneh Y, et al. Defining an optimal cut-off point for reticulocyte hemoglobin as a marker for iron deficiency anemia: An ROC analysis. PLOS ONE. 2023;18(7):e0288505. doi:10.1371/journal.pone.0288505
BibTeX
@article{Alzubi2023,
author = {Alzu'bi, Marah and Bawa'neh, Hisham and Alshorman, Alaa and Alrawabdeh, Jawad and Odeh, Nada and Hamadneh, Yazan and AlAdwan, Mai and Odeh, Mahmoud and Awidi, Abdalla},
title = {Defining an optimal cut-off point for reticulocyte hemoglobin as a marker for iron deficiency anemia: An ROC analysis},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {7},
pages = {e0288505},
doi = {10.1371/journal.pone.0288505}
}
EUVIMED